Novo Nordisk | SCHULD

Debt Veränderung Datum
ANI Pharmaceuticals USD 285.46M 212K 2024-03
Aurora Cannabis CAD 103.34M 23.67M 2023-12
Bausch Health Companies USD 22.07B 314M 2024-03
Bristol-Myers Squibb USD 57.41B 17.64B 2024-03
Canopy Growth CAD 668M 25.27M 2024-03
Catalent USD 4.99B 15M 2024-03
Corcept Therapeutics USD 76K 76K 2024-03
Drreddys Laboratories INR 19.85B 6.62B 2023-12
Eli Lilly USD 26.21B 6.04B 2024-03
GlaxoSmithKline GBP 17.77B 246M 2024-03
Merck USD 34.22B 640M 2024-03
Novartis USD 27.28B 936M 2024-03
Novo Nordisk DKK 26.93B 78M 2024-03
Pacira USD 581.78M 59.34M 2024-03
Perrigo USD 4.07B 7.9M 2024-03
Prestige Brands USD 1.14B 62.07M 2024-03
Supernus Pharmaceuticals USD 42.13M 438.74M 2024-03
Zoetis USD 6.77B 203M 2024-03



Novo Nordisk SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2024.